Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,454,864
+$9,738,997 QoQ
Shares Held
1,785,941
-0.1% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
3.62%
of 13F equity value
Holder Rank
#11
of 252 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2022CallValue
$5,165,536
CallShares
191,600
PutValue
$1,633,776
PutShares
60,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. CLDX ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
913,880 | $121,783,648 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
2,212,770 | $94,949,960 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
This page
|
1,785,941 | $66,454,864 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
2,798,210 | $61,168,870 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
664,684 | $52,702,794 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
798,973 | $45,389,656 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
629,952 | $36,619,109 | |
| 8 | GERN |
Geron Corp
|
18,717,422 | $23,958,300 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,454,864 | 1,785,941 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,715,867 | 1,788,016 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,967,131 | 1,434,725 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,851,910 | 1,153,920 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,068,277 | 838,736 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,641,456 | 696,499 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,190,255 | 719,836 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,201,018 | 564,902 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,427,885 | 633,015 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,845,496 | 711,115 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,907,883 | 754,107 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,185,695 | 588,143 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,660,158 | 785,740 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $24,814,542 | 689,676 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $24,904,557 | 558,774 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $17,607,316 | 626,372 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $5,165,536 | 191,600 | Call | Sole | 2023-11-08 | |
| 2022-06-30 | $1,633,776 | 60,600 | Put | Sole | 2023-11-08 | |
| 2022-06-30 | $14,892,380 | 552,388 | Shares | Sole | 2023-11-08 | |
| 2022-03-31 | $21,677,589 | 636,453 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $22,893,349 | 592,478 | Shares | Sole | 2023-11-08 | |
| 2020-09-30 | $2,231,826 | 150,494 | Shares | Sole | 2023-11-08 | |
| 2020-06-30 | $9,265,074 | 712,698 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||